About this trial
Children with developmental language disorders (DLD, aka specific language impairment), a prevalent pediatric disorder, experience hallmark grammar deficits with life-long impacts on educational and occupational outcomes. While effective and early interventions can mitigate the impact of DLD, not enough is known about the neural basis of DLD in young children, yet is needed to inform the design of more individualized interventions. This project uses neuroimaging, along with behavioral methods, with the goal of better understanding the memory-language mechanisms that underlie grammar learning and impairment, while also considering their association to treatment-related changes in preschoolers with DLD.
Eligibility criteria
Qualifiers
ages 48-71 months
average nonverbal intelligence quotient (IQ)
enrolled in participating center
typically developing (receptive and expressive language, social, articulation, other)
Disqualifiers
receiving co-occurring speech-language or other intervention for communication
not MRI safe
special education placement of child based on ability or behavior
Trial design
Treatments tested in this trial
- My Sentence Builder
Treatment groups
Sponsors and collaborators
University of Cincinnati
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Collaborator
University of Toronto
Collaborator